Enterprise Value

2.525B

Cash

470.5M

Avg Qtr Burn

N/A

Short % of Float

11.08%

Insider Ownership

0.51%

Institutional Own.

-

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Phase 3

Data readout

ACP-204 Details
Alzheimer's disease

Phase 2/3

Data readout

Failed

Discontinued

ACP-044 Details
Pain, Post operative acute pain

Failed

Discontinued

Failed

Discontinued